Update on HIV from the IDSA 44th annual meeting in Toronto.
Johnson
Kristine
K
Erbelding
Emily
E
D019969:Amphetamine-Related Disorders / Q000150:complications; D023241:Antiretroviral Therapy, Highly Active; D004352:Drug Resistance, Microbial; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000635:transmission; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D008694:Methamphetamine / Q000008:administration & dosage; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D009864:Ontario; D017201:Virus Shedding
D008694:Methamphetamine